BioCentury
ARTICLE | Company News

Sunshine Biopharma, Binghamton University deal

January 31, 2011 8:00 AM UTC

The biotech and university signed a three-year deal to conduct preclinical and Phase I testing of Sunshine's Adva-27a to treat breast and prostate cancer. Sunshine will provide partial funding and wi...